Notice of Annual and Special Meeting Of Shareholders Aug 19, 2022 Notice of Annual and Special Meeting Of Shareholders Notice of Meeting and Management Information Circular for the Annual And Special Meeting of Shareholders to be held on September 19, 2022 Form of Proxy Voting Instruction Form Request for Financial Statements Email Sign Up Success! First Name Last Name Email Subscribe Recent News Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024read more Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure Oct 31, 2024read more Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures Sep 18, 2024read more Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections Aug 28, 2024read more
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024read more
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure Oct 31, 2024read more
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures Sep 18, 2024read more
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections Aug 28, 2024read more
